Results 191 to 198 of about 983 (198)

SURWEY study of solriamfetol: initiation, titration, safety, efficacy, and follow-up experience for patients with OSA in Germany

Sleep Medicine
Y. Winter, G. Mayer, S. Kotterba, H. Benes, L. Burghaus, I. Abeynayake, S. Floam, H. Kwak, G. Parks, U. Kallweit   +9 more
semanticscholar   +1 more source

Solriamfetol Improves Cognitive Performance in Preclinical Models of Sleep Apnea and in a Randomized Placebo-controlled Study of Sleep Apnea Participants (SHARP) (P9-9.004)

Neurology
D. Gozal, H. Van Dongen, E. Leary, Gregory S Parks, S. Floam, H. Tabuteau   +5 more
semanticscholar   +1 more source

SURWEY Study of Solriamfetol: Initiation, Titration, Safety, Efficacy, and Follow-up Experience for Patients with OSA in Germany (P9-9.010)

Neurology
Y. Winter, Geert Mayer, H. Benes, L. Burghaus, I. Abeynayake, S. Floam, H. Kwak, Gregory S Parks, U. Kallweit   +8 more
semanticscholar   +1 more source

Solriamfetol improves cognitive performance in preclinical models of sleep apnea and in a randomized placebo-controlled study of sleep apnea participants (SHARP)

Sleep Medicine
D. Gozal, H. Van Dongen, E. Leary, G. Parks, S. Floam, H. Tabuteau   +5 more
semanticscholar   +1 more source

A Phase I, Randomized, Crossover, Open-label Study of the Pharmacokinetics of Solriamfetol (JZP-110) in Healthy Adult Subjects With and Without Food

Clinical Therapeutics, 2019
exaly  

First fluorescence method for monitoring the doping stimulant drug solriamfetol in plasma and urine: A pharmacokinetic study in volunteers’ urine with greenness, whiteness, and blueness assessments

Microchemical Journal
Hend. Z. Yamani
exaly  

Single‐Dose Pharmacokinetics and Safety of Solriamfetol in Participants With Normal or Impaired Renal Function and With End‐Stage Renal Disease Requiring Hemodialysis

Journal of Clinical Pharmacology, 2019
exaly  

Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma

Case Medical Research, 2019
openaire   +1 more source